OIC

10 More Newly Approved Drugs
10 More Newly Approved DrugsWhat you need to know about the the 10 newest FDA drug approvals.
FDA approves subcutaneous injection for opioid-induced constipation in chronic non-cancer painFDA approved methylnaltrexone bromide (Relistor, Salix Pharmaceuticals and Progenics Pharmaceuticals) subcutaneous injection, 12 mg/0.6 mL, for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain.
FDA approves first oral agent for OIC in adults with chronic noncancer painFDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.